Matthew Reiss MSE PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer, and Jared Weiss MD, Section Chief of Thoracic and Head & Neck Oncology, Professor of Medicine, University of North Carolina at Chapel Hill It is [...]
GO2 for Lung Cancer is excited to announce the publication of our brand-new handbook, Navigating Small Cell Lung Cancer: 360° of HOPE. Download or order your free hard copy today.  When you or someone you love is diagnosed with [...]
The American Society of Clinical Oncology (ASCO) hosts an annual meeting every spring. At this meeting, oncologists, physicians, researchers, industry members, advocacy organizations (like GO2,) patients, and caregivers come together to share and learn about the latest and most [...]
On June 13, 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval of Augtyro (repotrectinib) for adults and children aged 12 years and older with NTRK-positive solid tumors, including non-small cell lung cancer (NSCLC). The new approval [...]
Contributing Authors: Brittney Nichols, MPH, RN-BSN, Senior Specialist, Science and Research, GO2 for Lung Cancer; Andrew Ciupek, PhD, Associate Director, Clinical Research, GO2 for Lung Cancer; and Renee Botello, MSc, Navigator, Treatment and Trials, GO2 for Lung Cancer Every [...]
Jim Fackler lives in Lancaster, South Carolina, with his wife, Gail. He is a proud Vietnam veteran who served in the United States Navy. He enjoys golf, driving his pontoon on the lake, home improvement projects, and meeting [...]
On May 16, 2024, the U.S. Food and Drug Administration (FDA) granted Imdelltra (tarlatamab-dlle) accelerated approval for people with extensive stage small cell lung cancer (ES-SCLC) following progression on or after platinum-based chemotherapy. The approval is based on results [...]
Treatment options for people diagnosed or living with small cell lung cancer (SCLC) are constantly improving and expanding. In fact, there are more drugs in development right now than were developed in total over the last 50 years. Investments [...]
GO2 for Lung Cancer’s Small Cell Lung Cancer (SCLC) program offers education, support, and connection to those affected by SCLC. People living with SCLC often have different needs than those with non-small cell lung cancer (NSCLC). Our SCLC program aims [...]
By Mike Knecht  Mike Knecht retired from his career as an electrical contractor and business owner in 2019 and spent the following year traveling through the United States and Africa. In early 2023, he and his wife, Lois, sold their home in Maryland to live full-time in their vacation/retirement home in West [...]